Notice of Change to PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"
Notice Number:
NOT-DA-23-049

Key Dates

Release Date:

December 5, 2023

Related Announcements

  • June 14, 2023 - Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed).  See NOFO PAR-23-194 

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This notice informs applicants of a change to the PHS 398 Research Plan for PAR-23-194: Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed).

Part 2. Full Text of Announcement

Section IV. Application and Submission Information

PHS 398 Research Plan

Other Plan(s):

Note: Effective for due dates on or after January 25, 2023, the Data Management and Sharing Plan will be attached in the Other Plan(s) attachment in FORMS-H application forms packages.

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: 

Currently, reads:

Not Applicable

Revised to read (changes noted in bold italics): 

 

  • A Data Management and Sharing Plan is not applicable for this NOFO. 

 All other aspects of this PAR remain the same.

Inquiries

Please direct all inquiries to:

Marsha F. Lopez, Ph.D., M.H.S.
National Institute on Drug Abuse (NIDA)
Phone: 301-443-6504
Email: marsha.lopez@nih.gov

Keisher Highsmith, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-402-1984
Email: keisher.highsmith@nih.gov

Guifang Lao, M.D., Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-827-5931
Email: laog@mail.nih.gov

Beth Babecki, M.A.
National Institute on Drug Abuse (NIDA)
Phone: 301-435-0899
Email: bbabecki@nida.nih.gov

Lindsey Friend, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-402-1428
Email: lindsey.friend@nih.gov